Clinical Trials at Providence Regional Cancer System-Shelton

As of August 2026, 5 paid clinical trials are recruiting at Providence Regional Cancer System-Shelton in Shelton, Washington. Active studies at this site cover conditions such as Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8 and Clinical Stage IV Cutaneous Melanoma AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Filter results
Filter results
Recruitment status
Phase
Sex
Age

5 clinical trials at Providence Regional Cancer System-Shelton

·Clear filters·
Get a weekly email when new trials open in Shelton, WA.

Common conditions studied in Shelton

  • Acral Lentiginous Melanoma (1 active study)
  • Anatomic Stage IV Breast Cancer AJCC v8 (1 active study)
  • Clinical Stage IV Cutaneous Melanoma AJCC v8 (1 active study)
  • Elevated CA15-3 or CEA or CA27-29 (1 active study)
  • Estrogen Receptor Positive (1 active study)
  • HER2/Neu Negative (1 active study)

Leading research sponsors in Shelton

  • SWOG Cancer Research Network
  • ECOG-ACRIN Cancer Research Group
  • Fred Hutchinson Cancer Center

Frequently asked questions

How many paid clinical trials are currently recruiting in Shelton?

There are approximately 6 recruiting clinical trials in Shelton, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Shelton pay participants?

Most recruiting trials in Shelton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Shelton?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Shelton?

The most common conditions under active study in Shelton include Acral Lentiginous Melanoma (1), Anatomic Stage IV Breast Cancer AJCC v8 (1), Clinical Stage IV Cutaneous Melanoma AJCC v8 (1), Elevated CA15-3 or CEA or CA27-29 (1), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Shelton?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Shelton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Shelton?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Shelton?

Recruiting research sites in Shelton include Providence Regional Cancer System-Shelton, South Puget Intertribal Planning Agency (SPIPA), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Shelton right now?

The largest active categories in Shelton are Cancer & tumors (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Related healthcare resources in Washington

Trials by condition in Shelton